yishai ofran
yishai ofran
Hematology departmant Rambam Health Care Campus Haifa ISRAEL
Verified email at - Homepage
Cited by
Cited by
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ...
Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021
Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission
AH Wei, H Döhner, C Pocock, P Montesinos, B Afanasyev, H Dombret, ...
New England Journal of Medicine 383 (26), 2526-2537, 2020
Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Heuser, Y Ofran, N Boissel, SB Mauri, C Craddock, J Janssen, ...
Annals of Oncology 31 (6), 697-712, 2020
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death
JK Altman, A Rademaker, E Cull, BB Weitner, Y Ofran, TL Rosenblat, ...
Leukemia research 37 (9), 1004-1009, 2013
The QUAZAR AML-001 maintenance trial: results of a phase III international, randomized, double-blind, placebo-controlled study of CC-486 (oral formulation of azacitidine) in …
AH Wei, H Döhner, C Pocock, P Montesinos, B Afanasyev, H Dombret, ...
Blood 134, LBA-3, 2019
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial
I Oren, H Sprecher, R Finkelstein, S Hadad, A Neuberger, K Hussein, ...
American journal of infection control 41 (12), 1167-1172, 2013
Patterns of information-seeking for cancer on the internet: an analysis of real world data
Y Ofran, O Paltiel, D Pelleg, JM Rowe, E Yom-Tov
Public Library of Science 7 (9), e45921, 2012
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter …
P Montesinos, GJ Roboz, CE Bulabois, M Subklewe, U Platzbecker, ...
Leukemia 35 (1), 62-74, 2021
Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study
D Merkel, K Filanovsky, A Gafter‐Gvili, L Vidal, A Aviv, ME Gatt, ...
American journal of hematology 88 (2), 130-134, 2013
The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy
E Elinav, I Ben-Dov, E Hai-Am, Z Ackerman, Y Ofran
Journal of hepatology 42 (1), 82-86, 2005
Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations
RB Walter, Y Ofran, A Wierzbowska, F Ravandi, CS Hourigan, LL Ngai, ...
Leukemia 35 (6), 1529-1538, 2021
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
Y Ofran, S Ringelstein-Harlev, I Slouzkey, T Zuckerman, D Yehudai-Ofir, ...
Leukemia 34 (1), 293-295, 2020
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study
N Andria, O Henig, O Kotler, A Domchenko, I Oren, T Zuckerman, Y Ofran, ...
Journal of Antimicrobial Chemotherapy 70 (11), 3146-3153, 2015
Fatal voluntary salt intake resulting in the highest ever documented sodium plasma level in adults (255 mmol L−1): a disorder linked to female gender and …
Y Ofran, D Lavi, D Opher, TA Weiss, E Elinav
Journal of internal medicine 256 (6), 525-528, 2004
Genetic profiling in acute myeloid leukaemia─ where are we and what is its role in patient management
Y Ofran, JM Rowe
British journal of haematology 160 (3), 303-320, 2013
Treatment for relapsed acute myeloid leukemia: what is new?
Y Ofran, JM Rowe
Current opinion in hematology 19 (2), 89-94, 2012
Near‐fatal amitraz intoxication: The overlooked pesticide
E Elinav, Y Shapira, Y Ofran, T Hassin, IZ Ben‐Dov
Basic & clinical pharmacology & toxicology 97 (3), 185-187, 2005
Granulocyte transfusions for neutropenic patients with life‐threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions
Y Ofran, I Avivi, A Oliven, I Oren, T Zuckerman, L Bonstein, JM Rowe, ...
Vox sanguinis 93 (4), 363-369, 2007
BCR-ABL (Ph)-like acute leukemia—pathogenesis, diagnosis and therapeutic options
Y Ofran, S Izraeli
Blood reviews 31 (2), 11-16, 2017
How I treat acute myeloid leukemia presenting with preexisting comorbidities
Y Ofran, MS Tallman, JM Rowe
Blood, The Journal of the American Society of Hematology 128 (4), 488-496, 2016
The system can't perform the operation now. Try again later.
Articles 1–20